SEC Filing Summary: New Residential Investment Corp. (NRZ)
Business Context and Reporting Period
This Form 8-K was filed on June 26, 2019, reporting events occurring on June 25, 2019. The registrant, New Residential Investment Corp. (NRZ), is a Delaware corporation listed on the NYSE. The filing details the entry into a material definitive agreement regarding a new equity offering.
Key Financial Metrics and Transaction Details
The filing does not provide standard operating metrics such as revenue, profit, cash flow, or margins for a specific reporting period. Instead, it outlines the following capital structure transaction:
- Security Issued: 7.50% Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock.
- Shares Sold: 5,400,000 shares.
- Liquidation Preference: $25.00 per share.
- Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional 810,000 shares.
- Underwriter: BofA Securities Inc. (representative).
- Expected Closing Date: July 2, 2019.
Material Changes
The primary material change is the execution of an underwriting agreement to raise capital through the issuance of preferred stock. This represents a significant change in the company's capital structure pending the closing of the transaction.
Outlook, Management Commentary, and Risks
Use of Proceeds: Net proceeds from the offering are expected to be used for investments and general corporate purposes.
Related Party Transactions: Certain underwriters and their affiliates have provided and may continue to provide investment banking, financing, trading, and other services to the Company, for which fees are received. They may also sell assets to the Company.
Risks and Contingencies: The closing is subject to customary conditions. The Company has agreed to indemnify underwriters against certain liabilities under the Securities Act of 1933 and to contribute to payments if indemnification cannot be provided.
Investor Verification Checklist
- Verify the final closing date of the offering (expected July 2, 2019) and whether the over-allotment option was exercised.
- Confirm the actual net proceeds received after deducting underwriting discounts and commissions.
- Review the full Underwriting Agreement (Exhibit 1.1) for specific redemption terms and floating rate mechanics.
- Monitor subsequent filings for the impact of this preferred stock issuance on the company's dividend obligations and balance sheet leverage.